Ignite Creation Date:
2024-05-06 @ 3:48 PM
Last Modification Date:
2024-10-26 @ 1:57 PM
Study NCT ID:
NCT04764942
Status:
RECRUITING
Last Update Posted:
2024-01-17
First Post:
2021-02-17
Brief Title:
Selinexor Pomalidomide and Dexamethasone With or Without Carfilzomib for the Treatment of Patients With Relapsed Refractory Multiple Myeloma The SCOPE Trial
Sponsor:
Organization:
Mayo Clinic